About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Vitamin D Influence on Oocyte Donation | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT02341365

Vitamin D Influence on Oocyte Donation

Objective: To investigate the correlation between total and bioavailable serum 25-OH vitamin D, ovarian reserve and ovarian response to controlled stimulation in egg donors.

Lead sponsor: IVI Madrid•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

IVI Madrid

Design: Retrospective study. Setting: University affiliated private IVF center. Intervention: Serum analysis of vitamin D, bioavailable vitamin D, antimullerian hormone (AMH), antral follicular count (AFC), reproductive outcome of oocytes recipients Main outcome measure: AMH, AFC, number of oocytes retrieved and number of mature oocytes, pregnancy and implantation rate of donated oocytes'recipients.

Age

18 - 34 years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Caucasian race,
•between 18 and 34 years of age,
•all donors had normal menstrual cycles of 26-34 days,
•normal weight range (BMI 18- 25 Kg/m2),
•normal uterus and ovaries on transvaginal ultrasound (no signs of polycystic ovarian syndrome), and
•an antral follicle count (AFC) \>10,
•normal karyotype

Exclusion Criteria

•current or past exposure to radiation or hazardous chemical substances,
•history of drug use,
•family history of hereditary chromosomal diseases,
•sexually transmitted diseases

Related studies

COMPLETEDPhase 4

Antagonist Protocol in Poor Responders

NCT02195947 · Female Infertility Due to Diminished Ovarian Reserve

UNKNOWNPhase 1/2

Effect of Testosterone Treatment on Embryo Quality

NCT01662466 · Primary Ovarian Insufficiency, Female Infertility Due to Diminished Ovarian Reserve

UNKNOWNPhase 1/2

Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF

NCT02179255 · Female Infertility Due to Diminished Ovarian Reserve

COMPLETEDPhase 4

IVF/ICSI Protocols in Poor Responders With Growth Hormone

NCT01897324 · Female Infertility Due to Diminished Ovarian Reserve

COMPLETEDPhase 4

Microflare Protocol in Poor Responders

NCT02185326 · Female Infertility Due to Diminished Ovarian Reserve

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 19, 2015Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment269

Start dateJun 2013

Last updatedJan 19, 2015

Condition

Disorder of Phosphate, Calcium and Vitamin D Metabolism Female Infertility Due to Diminished Ovarian Reserve Hormonal Requirement Reproductive Disorder

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 19, 2015Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions